Miquel Vila  Bover

Miquel Vila Bover

Vall d'Hebron Institut de Recerca

Life & Medical Sciences

Miquel Vila received his MD from the University of Barcelona (Spain) and then moved to the laboratory INSERM U289 (Prof. Y. Agid) at the Salpêtrière Hospital (Paris, France), where he obtained a Master degree (DEA) and PhD in Neuroscience from the University of Paris 6. From 1998 to 2001 he worked as a postdoctoral researcher at the laboratory of Dr. S. Przedborski at the Dept. of Neurology of Columbia University (New York, USA). In 2001, he obtained a tenure-track position as Assistant Professor of Neurology at Columbia University, a $1M-R01 NIH grant and the US permanent residency (outstanding researcher category). In December 2005, he moved back to Barcelona as an ICREA Research Professor to create and lead a new research group on Neurodegeneration at the Vall d'Hebron Research Institute, with the support of a 1.5M€ European Commission's Marie Curie Excellence Grant. He also holds positions as Associate Professor at the UAB and as Principal Investigator at the CIBERNED.

Research interests

Our research is geared toward elucidating the molecular mechanisms of neuron cell death occurring in Parkinson's disease, the second most common neurodegenerative disorder after Alzheimer's dementia, in order to: (i) identify biomarkers for the diagnosis, early detection, patient stratification, disease progression, prognosis or response to treatment, (ii) identify new molecular targets for potential therapeutic intervention, (iii) develop novel therapeutic strategies with disease-modifying potential for this currently incurable disease, (iv) unravel molecular pathways common to other neurodegenerative diseases.

Selected publications

- Chocarro J, Rico AJ, Ariznabarreta G, et al. 2023, 'Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates', Brain, 146, 12, 5000-5014.
- Teil M, Dovero S, Bourdenx M, et al. 2023, 'Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.', Npj Parkinson's Disease, 9, 1, 135.
- de Fàbregues O, Sellés M, Ramos-Vicente D, Roch G, Vila M & Bové J 2023, 'Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?', Neurobiology Of Disease, 187, 106308.
- Gonzalez-Sepulveda M, Compte J, Cuadros T, et al. 2023, 'In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease', Brain, 146, 3, 1040-1052.

Selected research activities

  • Organization of the 6th World Parkinson Congress 2023 (Barcelona, Spain), as co-Chair of the Local Organizing Committee, Member of the Basic Science Program Committee and Member of the Steering Committee of the World Parkinson Coalition.
  • Member of the the Steering Committee of the International Parkinson and Movement Disorder Society (MDS) Basic Science Special Interest Group (MDS-BSSIG), which oversees the development of educational programs worldwide and interacts with the MDS leadership to promote and survey interest in Basic Science of Movement Disorders.
  • Co-organizer, Co-Director and Faculty of the MDS-European Section Course Controversies in Parkinsons’s Disease Research, Bordeaux, France (2023).